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The C3b  inactivator  (C3bINA)  I  has  been  reported  to  cleave  and  inactivate  cell- 
bound C3b (1,  2),  C3b in  solution  (3),  and cell-bound  and free  CAb (4,  5).  In  this 
capacity  it  constitutes  an important regulatory  protein  of  the classical  (6)  and 
alternative  complement pathways (7, 8). Its  physiological  role  in complement 
homeostasis has become apparent through the observation of two cases of 
homozygous C3bINA deficiency  (9, 10),  which are associated  with C3 hyperca- 
tabolism and increased susceptibility  to severe  bacterial  infections  (11).  Re- 
cently, the serum protein ~IH (12)  has been identified  as an accelerating 
cofactor  (13)  of  C3bINA and has been shown to have, in addition,  independent 
regulatory  functions  in  the alternative  pathway (8, 14). 
Although the enzyme was described  as  C3bINA in  1966 (1)  and as  conglutino- 
gen activating  factor  in  1968  (2),  the  enzyme has  not  been  obtained  heretofore  as 
a homogeneous protein.  As a consequence, the precise  mechanism of  action  on 
C3b and CAb could not be clearly  defined.  It  is  widely believed,  however, that 
C3bINA is  responsible  for  cleavage of  C3b into  the C3c and C3d fragments (3). 
The purpose of  this  paper is  to describe  a method of  isolation  of  C3bINA from 
human serum, its  physical  and chemical properties,  its BIH cofactor  require- 
ment and the products of its proteolytic  action  on C3b and C4b. One of the 
results  obtained indicates  that action  of  the C3bINA and its cofactor  BIH on 
soluble  C3b does not  geneate  the immunochemically defined  fragments  C3c and 
C3d. 
Materials and Methods 
Materials.  The following materials  were parchased  from the sources indicated:  serum was 
obtained  from freshly drawn  O  positive human  blood,  purchased  from Community Blood and 
Plasma  Service,  San  Diego,  Calif.;  DEAE-cellulose  (DE  52)  from  Whatman  Chemicals,  Div. 
*  Publication  no.  1295.  Supported  by  U.  S.  Public  Health  Service  grants  A107007  and  HL 16411. 
Recipient  of  an Established  Investigatorship  (no.  77 202)  from  the  American  Heart  Associa- 
tion. 
§ Cecil  H. and Ida M. Green Investigator  in Medical Research,  Scripps  Clinic  and Research 
Foundation. 
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sodium dodecyl sulfate. 
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W  &  R  Balston,  Maidstone,  Kent,  England; CNBr-Sepharose,  Pharmacia  Fine  Chemicals, 
Piscataway, N.  J.; guanidine HC1, ultrapure grade, Schwarz/Mann Div., Becton,  Dickinson & 
Co., Orangeburg, N. Y.; dithiothreitol (DTT), Bio-Rad Laboratories, Richmond,  Calif.;  fuchsin- 
sulfite stain (Schiff reagent) from Harleco,  Gibbstown, N. J.; and crystallized bovine serum al- 
bumin, Calbiochem, San Diego, Calif. 
Purified Complement Components and Reagents.  C1 (15), C2 (16), C4 (17), and C3 (12, 18) were 
isolated as described previously. C2 was  used exclusively in the oxidized  form  (19). CI~ was 
isolated by a modification (20) of the previously published method (21). fllH was purified from a 
pH 5.8 euglobulin precipitate of fresh human serum by gel filtration on BioGel A1.5M (Bio-Rad 
Laboratories), DEAE-cellulose chromatography, hydroxyapatite chromatography, and finally by 
chromatography over an anti-IgGSepharose immune adsorbent. The product was free of C3bINA 
and gave a single precipitin line in immunoelectrophoresis versus anti-whole human serum. It 
also appeared to be homogeneous upon electrophoresis in sodium dodecyl sulfate (SDS) polyacryl- 
amide gels. The cellular intermediate EAC423 was prepared by published methods (22) by using 
limiting C3 concentrations. Hemolytic assays with these cells utilized a C5-9 reagent prepared 
from serum immunochemically  depleted of C3bINA. This depleted serum was then treated with 
0.015 M hydrazine at 37°C for 45 min and dialyzed versus veronal buffer containing  0.15 × 10  -3 M 
CaC12 and 1  ×  10  -3 M MgC12. 
Preparation of Radiolabeled  Proteins.  Purified C3bINA, C3, and C4 were radiolabeled using 
bovine lactoperoxidase  covalently  coupled to Sepharose 4B as described by David and Reisfeld (23). 
Uptake of iodine was approximately 10% and the specific radioactivity of C3bINA was 0.37 ~Ci/ 
~g, of C3b was 0.22 ~Ci//~g, and that of CA was 0.6 ~Ci/~zg. 
Preparation of Immune Adsorbents.  Anti-C3bINA, anti-IgG, and anti-fllH adsorbents were 
prepared by coupling the IgG fractions (40% ammonium sulfate precipitates) of goat antisera to 
CNBr-Sepharose  utilizing  the method of March et al. (24). The anti-C3bINA  used in this study was 
raised in a goat by using C3bINA purified on an immune adsorbent prepared from rabbit anti- 
C3bINA. This original antisera was a gift from Dr. Clark West. 
Amino Acid Analysis.  Amino acid analyses were performed on a Beckman 121-M amino acid 
analyzer (Beckman Instruments, Inc., Cedar Grove, N. J.). Samples were hydrolyzed for 24, 48, 
and 72 h with twice distilled, constant boiling 6 N HC1 at 110°C in evacuated tubes. Tryptophan 
was determined after alkaline hydrolysis (25). Half-cystine and methionine  were determined after 
performic acid oxidation. 
Electrophoresis.  Disk electrophoresis was performed by using the method of Davis (26) as 
modified by Clarke (27) in 6% polyacrylamide running  gels and Tris-HCl-glycine  buffer, pH 8.9. 
SDS polyacrylamide gel electrophoresis was performed according to the method of Weber and 
Osbern (28) as reported previously (29). Densi~metry analysis of stained gels was performed by 
using a Gilford recording spectrophotometer equipped with a linear transport unit. Gels stained 
with Coomassie brillant Blue were scanned at 625 nm and those stained for carbohydrate by the 
periodic acid-Schifftechnique (30) were scanned at 540 nm. Immunoelectrophoresis  was performed 
in 1.2% agarose (Marine Colloids, Inc., Rockland, Maine) in barbital buffer, pH 8.6, ionic strength 
0.05, according to the method of Scheidegger (31). 
Results 
Isolation of C3bINA.  Fresh serum was brought to a  final concentration of 
0.02 M EDTA and 0.5 M NaC1 by the addition of 0.2 M EDTA and solid NaC1. 
This solution was applied to a column ofanti-C3bINA Sepharose (Fig. 1) and the 
column was washed with a  buffer containing 0.5 M NaC1,  0.01 M PO4,  0.02 M 
EDTA, pH 7.0, and 20% (wt/vol) sucrose. It was found that high concentrations 
of sucrose eluted a significant amount of protein which was probably bound to 
the  polysaccharide  backbone  of Sepharose.  After  a  second  wash  with  buffer 
without sucrose, C3bINA was eluted with 2 M guanidine-HC1, containing 0.01 M 
sodium phosphate, 0.02 M EDTA, and 0.5 M NaC1. The material eluting with 2 
M guanidine contained 47% of the applied C3bINA, but only 0.3% of the protein, 
a  142-fold purification (Table I). M.  K.  PANGBURN,  R.  D.  SCHREIBER,  AND  H.  J.  MULLER-EBERHARD  259 
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FIG. i.  Affinity  chromatography of  serum on anti-C3bINA Sepharose. Fresh serum (110 
m]) containing 1.9 × 108 cpm I~sI-C3bINA (5.1  p~),  0.02  M  EDTA, and 0.5 M  NaCl was 
applied  to  a 5.6  x 6.2-cm column  of  anti-C3bINA  Sepharose  equilibrated  with  0.01  M sodium 
phosphate, 0.002  M EDTA, and  0.5  M  NaCI  at  pH 7.0.  The  column  was  then  washed  with  200 
ml of  equilibrating  buffer,  200 ml of  the same buffer  containing 20% sucrose,  and another 
200 ml  of  equilibrating  buffer.  C3bINA was eluted  with  200  ml of  2 M guanidine-HCl in  the 
equilibrating  buffer.  C3bINA containing fractions  were pooled as indicated  by the bar. 
TABLE  I 
Purification and Yield of Human C3blNA Isolation 
C3bINA 
Total  Con-  Total  Yield  Overall  Purification 
Material  Volume  pro- 
tein*  centra-  C3bINA  per step  yield  Per  step  Total 
tion~ 
ml  mg  pglml  mg 
Serum  110  7,260  29  3.2  -  -  1  1 
Anti-C3bINA  col-  9  24  145  1.5  47%  47%  142  142 
umn pool 
DEAE-cellulose  0.5  0.63  1,000  0.5  33%  16%  12.7  1,810 
pool 
Anti-IgG column  0.5  0.40  800  0.4  80%  13%  1.26  2,270 
pool 
* Protein  concentration determined by Folin  analysis  by using  crystalline  bovine  serum albumin 
as a standard. 
C3bINA concentration was determined by radial  immunodiffusion. 
C3bINA eluted from the affinity column was dialyzed against 0.85%  saline, 
0.002  M  EDTA  at  pH  7.2,  concentrated  by  ultrafiltration  and  subsequently 
dialyzed against a  solution of 0.008 M  sodium phosphate, 0.005 M  NaC1, pH 7.8, 
with a conductance at 21°C of 2.0 mmho/cm. This solution was applied to a column 
of DEAE-cellulose  equilibrated  with the  same buffer (Fig.  2).  The column was 
washed with three column volumes of starting buffer and C3bINA was subse- 
quently  eluted  with  a  buffer of slightly higher  sodium chloride  concentration 
and a conductance of 4.1 mmho/cm. Although the yield of this step was only 33%, 
the  protein  eluted  at  4.1  mmho  was  85%  C3bINA  and  the  only  detectable 260  HUMAN  c3b  INACTIVATOR 
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Fro.  2.  Chromatography on DEAE-cellulose of pooled C3bINA from anti-C3bINA Sepha- 
rose column.  The concentrated sample was dialyzed in 10 liters of 0.008 M  sodium phos- 
phate, 0.005 M NaC1, pH 7.9, conductance 2.0 mmho/cm (21°C),  and applied to a 1.4 ×  10 cm 
DEAE-cellulose column equilibrated with the same buffer. Elution of C3bINA was accom- 
plished using the equilibrating buffer brought to a conductance of 4.1 mmho/cm with NaC1. 
C3bINA  activity  is  given  as  percent  inhibition of hemolytic  sites  on  EAC4-~  cells  as 
described in Methods. C3bINA was pooled as indicated by the bar. 
FIG.  3.  Disk  gel  electrophoresis  of purified  C3bINA  in  6%  polyacrylamide  at  pH  8.9. 
C3bINA  (40  ~g)  containing  4  ng  I~I-C3bINA  was  applied  to  each  of two  gels.  After 
electrophoresis one gel was stained with Coomassie Blue dye and photographed. The other 
gel was sliced into 2-mm segments and eluted with 200/~1 of PBS for 24 h. The slices were 
counted for radioaqtivity and assayed for the ability to destroy hemolytic sites on EAC423 
cells. Activity is given as the decrease in adsorbance at 412 nm indicating decreased lysis. 
contaminant was IgG. This protein was removed by passing the mixture over an 
anti-IgG Sepharose column. The resulting protein was homogeneous by all gel 
electrophoretic and  immunological criteria  tested.  Fig.  3  demonstrates  that 
upon disk gel electrophoresis at pH 8.9 a single protein band was observed upon 
staining with  Coomassie Blue.  The position of this  band as well as the I~I- 
C3bINA peak corresponded to the position of enzymatic activity toward cell- 
bound C3b which was eluted from slices of  a similar gel. Immunoelectrophoresis 
of  purified C3bINA (Fig. 4) showed a single precipitin arc with anti-C3bINA. No 
contaminating antigens could be detected with anti-whole human serum. The 
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FIG.  4.  Immunoelectrophoresis of purified C3bINA.  The upper  slide demonstrates  the 
absence  of contaminating  antigens  in  purified C3bINA with  rabbit  anti-whole human 
serum (WHS) (upper well: 2 ~l WHS containing 68 ng C3bINA; lower well: 3/~1 containing 
1,920 ng purified C3bINA).  The lower slide demonstrates the immunoelectrophoretic simi- 
larity of purified C3bINA with the protein found in normal human serum (upper well: 25 ~1 
WHS containing 850 rig C3bINA; lower well: 3/~l containing 1,920 ng purified C3bINA). The 
lower slide also demonstrates the monospecificity of the anti-C3bINA antisera. The anode is 
to the right. 
Structural Properties: Molecular Weight, Subunits, Amino Acid, and Carbo- 
hydrate  Content.  Purified  C3bINA  was  subjected to  electrophoresis in  7% 
polyacrylamide gels  containing SDS.  Fig.  5  shows  that  before reduction of 
disulfide bonds the protein migrated as a single band and had an apparent mol 
wt of 73,000 daltons.  Upon reduction, two polypeptide chains were separated 
having tool wt of 50,000 and 38,000 daltons. The mol wt of intact C3bINA was 
therefore determined to be 88,000 daltons.  Both chains of this molecule were 
deomonstrated to contain carbohydrate by periodic acid-Schiff staining of the 
separated chains on SDS gels. As shown in Table H, the ratios of the amount of 
protein-bound stain (Coomassie) correspond well to the molecular weight ratios 
for the respective polypeptide chains. The ratios of carbohydrate-bound stain in 
the two chains, however, indicates that the smaller chain contains the majority 
of the C3bINA-bound carbohydrates. A schematic drawing of the tertiary struc- 
ture of the C3bINA molecule is shown in Fig. 6. Total hexose determinations by 
the phenol-sulfuric acid method gave a value of 7.5/~g hexose/100/~g C3bINA. 
Amino acid analysis for amino sugars yielded 3.2  fig of glucosamine/100 /~g 
C3bINA. Since glucosamine does not react with the phenolsulfuric acid reagent, 
these values must be  added to  obtain the carbohydrate content of C3bINA, 
which is at least 10.7% not including neuraminic acid. 
The amino acid composition of C3bINA is shown in Table III, calculated for a 
mol wt of  88,000 daltons. The composition suggests no unusual characteristics. 
Normal  Serum  Concentration.  The  protein  concentration  of  purified 
C3bINA was determined by amino acid analysis and by Folin analysis with 
bovine serum albumin as the reference  protein. Purified C3bINA was then used 
to standardize radial immunodiffusion  plates prepared with monospecific anti- 262  HUMAN  C3b  INACTIVATOR 
FIG. 5.  SDS polyacrylamide gel electrophoresis of purified C3bINA. The subunit  structure 
of C3bINA was examined by subjecting reduced and unreduced samples (70 I~g) to electro- 
phoresis through 7% polyacrylamide gels containing  0.1% SDS. Staining  of the protein with 
Coomassie Blue demonstrated that the unreduced protein migrated as a single band which 
upon reduction dissociated into two polypeptide chains. A similar gel containing 21  /~g 
C3bINA was stained for carbohydrate (right) by the periodic acid-Schiff technique. 
C3bINA prepared in a goat. 20 normal sera, quantitated by radial immunodiffu- 
sion, contained an average of 34 +_ 7/~g C3bINA/ml (mean +_ 1 SD). The highest 
concentration found was 49 ftg/ml and the lowest was 23  ~g/ml. 
Requirement of fllH for the Cleavage of  Free C3b by C3bINA.  Treatment of 
C3b with purified C3bINA at a concentration equivalent to that found in normal 
human serum for 60 min at 37°C had no effect on the structure of C3b (Fig. 7). 
C3b which had not been treated with anti-B1H Sepharose, however, was cleaved 
slowly by C3bINA due to  the presence  of a  low level  of ~IH  which  usually 
contaminates preparations  of C3.  When C3b was incubated with C3bINA and 
~IH,  both present in concentrations  similar  to those found in serum,  the  a'- 
chain of C3b (110,000 daltons) was cleaved into two fragments having mol wt of 
67,000 and 40,000 daltons. These fragments will be referred to as a'-67 and a'-40. M.  K.  PANGBURN,  R.  D.  SCHREIBER,  AND  H.  J.  MULLER-EBERHARD  263 
TABLE  II 
C3bINA Polypeptide Chains: Comparison of Molecular Weight, 
Protein, and Carbohydrate Staining  after SDS Polyacrylamide 
Gel Electrophoresis 
Chain  Mol wt 
Proportion  Proportion  Proportion 
based on tool  based on pro-  based on CHO 
wt*  tein stain*  stain§ 
%  %  % 
50,000  57  56  41 
fl  38,000  43  44  59 
* Molecular weight determined by relative migration in 7% polyacryl- 
amide gels containing SDS. 
* Protein  bands  stained  with  Coomassie  brilliant  Blue  R  250  and 
scanned as described in Methods. 
§ Gels stained  for carbohydrate  by the periodic  acid-Schiff technique 
and scanned as described in Methods. 
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Fro.  6.  Schematic representation of the subunit structure of human C3bINA. The dispro- 
portionate carbohydrate (CHO) content shown here is meant to reflect the 2:3 (a:fl) carbohy- 
drate ratio found in SDS gels stained for carbohydrate. The actual number of carbohydrate 
attachment sites and interchain disulfide bonds is unknown. 
Neither of the fragments were released from C3b in the presence of SDS without 
reduction. Dissociation of a'-67 and a'-40 from the apparently intact fl-chain 
required treatment with ITI'r. Cleavage in the presence of fllH was complete 
after 5 min and no additional cleavages occurred during 60 min of incubation 
(Fig.  7).  The  sum  of the  molecular weights  of a'-67  and  a'-40  equals  the 
molecular weight of the a'-chain. No precursor of the two fragments other than 
the a'-chain could be detected in a time-course experiment utilizing 1/loth of the 
above indicated concentrations of C3bINA  and  BIH  and extending over an 
observation period of 10-120 min at 37°C (lower right panel, Fig. 7). 
For the formation of C3c and C3d from C3b, trypsin treatment was required in 
addition to  treatment with C3bINA and fllH.  C3b  was first incubated with 
normal serum concentrations of C3bINA and fllH for 15 min at 37°C and then 
treated with 1/~g/ml trypsin for 30 min at 37°C. This treatment generated 27,000 
and 140,000 dalton fragments which could be separated on SDS polyacrylamide 
gel electrophoresis without reduction. No fragments were released from unre- 
duced C3b  by trypsin  under these conditions without prior  treatment with 
C3bINA and fllH. 
Requirement of fllH for the Cleavage of  Free C4b by C3bINA.  Native C4 is 
composed of three polypeptide chains referred to as a, 8, and ~ chains with mol 
wt of 93,000, 78,000, and 33,000 daltons, respectively (17). Treatment of C4 with 
CI~ cleaves the C4a fragment from the a-chain, leaving the 86,000 mol wt a'- 
chain of C4b. Incubation of C4b with buffer, with C3bINA, or with fllH for 2 h at 264  HUMAN  C3b  INACTIVATOR 
TABLE III 
Amino Acid Composition of Human C3bINA * 
Amino acid  Residues$/Molecule  Residues/I,000 Resi- 
dues 
Lysine  58  75 
Histidine  17  21 
Arginine  30  39 
Aspartic acid  77  99 
Threonine  45§  58§ 
Serine  61§  78§ 
Glutamic acid  87  111 
Proline  32  41 
Glycine  73  94 
Alanine  45  57 
Half-cystine  4~1  5~I 
Valine  51¶  65¶ 
Methionine  11§  14§ 
Igoleucine  35¶  45¶ 
Leucine  43  55 
Tyrosine  31§  40§ 
Phenylalanine  28  36 
Tryptophan  14"*  18"* 
Total  780  1,000 
* Reported as moles of amino acid per mole of protein, assuming a mol 
wt of 88,000 daltons. 
Average values from two replicates at each hydrolysis time (24, 48, 
and 72 h). 
§ Extrapolated to zero time of hydrolysis. 
II Determined after performic acid oxidation. 
¶ Value for 72 h hydrolysis. 
** Determined after base hydrolysis (25). 
37°C did not alter the structure of the C4b molecule (Fig. 8). Cleavage of the a'- 
chain of C4b could, however, be accomplished by C3bINA in the presence of 
BIH.  The  lower right panel  of Fig.  8  demonstrates that  the  simultaneous 
presence of  these two proteins results in the complete loss of  the a'-chain and the 
appearance of at least three fragments. These fragments have approximate mol 
wt of 49,000,  29,000,  and 10-20,000 daltens. When a similar digest of C4b was 
subjected to gel electrophoresis in SDS without the reducing agent DTT, only 
the 49,000 tool wt fragment was released (Fig. 9). This suggests that the 49,000 
mol wt fragment represents the nondisulfide bonded C4d portion of the molecule 
(5) and that the smaller fragments of the a'-chain are covalently linked to the 
or ~/chains of the molecule. Incubation of radiolabled C4 with C3bINA and ~IH 
did not alter the native three chain structure of C4, but some cleavage products 
appeared which probably originated from a small amount of C4b in the C4 (left 
panels, Fig. 8). 
Discussion 
This paper describes the first method for the purification of C3bINA as a 
homogeneous protein. It reports the C3bINA concentration in normal human 
serum to be 34 _+ 7 ~g/ml. It shows the enzyme to be composed to two nonidenti- M.  K.  PANGBURN,  R.  D.  SCHREIBER,  AND  H.  J.  MULLER-EBERHARD  265 
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FIG. 7.  Cleavage of C3b by C3bINA and fllH. Radiolabeled C3b (25 ~g/ml) which had been 
treated with anti-B1H Sepharose was incubated with buffer or with 26 ftg/ml C3bINA for 60 
rain at 37°C in a total vol of 20 ~. The mixture was denatured and reduced with an SDS- 
urea-DTT solution and applied to 7% SDS polyacrylamide gels. C3b treated with 500 ~g/ml 
BIH under the same conditions gave a pattern identical to that shown for C3b alone. SDS 
gels of C3b incubated with both C3bINA (26 p~g/ml)  and fllH (500/~g/ml) for 60 rain at 37°C, 
or with 1/lOth these concentrations for 120 rain at 37°C, are shown in the panels on the right. 
The mol wt of  the a'-chain of C3b is 110,000 daltons and that of  the B-chain is 75,000 daltons. 
The percent of  the total recovered radioactivity found in the major fragments is written near 
each peak. 
cal polypeptide chains which are linked by disulfide and noncovalent bonds. It 
delineates the chemical composition of the protein and the requirement of the 
cofactor/31H for its action on free C3b and C4b. 
The  purification of human  C3bINA  was  greatly  simplified by the  use  of 
immune adsorption on anti-C3bINA Sepharose. A single chromatographic sepa- 
ration on DEAE-cellulose of the eluate from the immune adsorption step ren- 
dered the protein 85% pure. Removal of contaminating IgG gave the product 
described in this study. The enzyme migrated as a single molecular species on 
polyacrylamide gel electrophoresis at  pH 8.9 and  C3bINA  activity could be 
eluted from the region of the gel corresponding to the protein band. The protein 
appeared to be homogeneous  and free of  contaminating antigens upon immunoe- 
lectrophoresis by using an antiserum to whole human serum. Furthermore, a 
monospecific antiserum was raised in a  goat after injection of highly purified 
C3bINA. 
Polyacrylamide gel  electrophoresis in  the presence of SDS  indicated that 
human C3bINA was composed of two polypeptide chains covalently linked by 
disulfide bonds. These chains had tool wt of 50,000 and 38,000 daltons and were 266  HUMAN  C3b  INACTIVATOR 
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Fro.  8.  The effect of C3bINA on the structure of C4 and C4b in the presence and absence of 
fllH. 125I-C4 (7 × 105 cpm/~g) or 12~I-C4b (prepared from 1~5I-C4 by incubation with CI~ for 30 
min at 37°C) were incubated with 0.8 ~g C3bINA and where appropriate, 17 ~g ~IH for 2 h 
at 37°C  in a  total vol of 25  ~1. Approximately 8  ×  104 cpm were applied to each gel after 
denaturation and reduction in SDS-urea-D2~l  ~. Electrophoresis was performed in 7% poly- 
acrylamide  gels.  The  origin  is  at  the  left.  The  upper  two  panels  show  the  results  of 
incubations with C3bINA alone. Incubations with buffer or with ~IH alone were essentially 
identical to these patterns.  The percent of the total recovered radioactivity found in the 
major fragments is written near each peak. 
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FIG.  9.  SDS polyacrylamide gel electrophoresis of an unreduced sample of 125I-C4b after 
treatment with C3bINA and B1H. The sample was prepared as described in Fig. 8, except 
that DTT was not used. 
designated  a  and  ~,  respectively, following the convention used with  other 
complement proteins.  Carbohydrate analyses indicated that the molecule con- 
tained 7.5% (wt/wt) hexose and 3.2% glucosamine, or at least 10.7% carbohydrate 
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unevenly between the a and fl chain, the smaller chain containing almost 60% of 
the carbohydrate. 
The amino acid composition  reported here is similar to that of other globulins, 
except for an above average content ofhalf-cystine residues. While this value (42 
residues per molecule or 5.4%) does not suggest any unusual properties, it may 
explain the stability of C3bINA to denaturation at pH 2.2 or by 2 M guanidine. 
The physiological function of C3bINA has long been understood to be the 
cleavage of the  C3b molecule which results  in the  abrogation of all  known 
functions associated with C3b: the classical (32) and alternative (7, 8) pathway 
C5 convertases are inactivated, the immune adherence and opsonizing functions 
are lost (33), and the C3b-dependent positive feedback activity is destroyed (34). 
Concomitant with the loss of C3b activities, the reactivity with cellular C3d 
receptors (35) and with conglutinin (2) appears. 
From previous studies it was concluded that proteolytic cleavage of the a'- 
chain of C3b (36, 37) by C3bINA splits the molecule into the immunochemically 
defined fragments C3c  and  C3d  (38). Our results  indicate that  in  complete 
absence of/31H, C3bINA does not cleave C3b in solution (Fig. 8). The previous 
observations of lack of ~IH requirement for C3bINA action is attributable to the 
occurrence of small amounts of B1H in most preparations of highly purified C3. 
Removal of traces of fllH from the C3 used in this study was accomplished by 
immune adsorption with anti-BllH Sepharose. Action of C3bINA and fllH on 
C3b results in cleavage of the a'-chain into two fragments which do not dissociate 
without reduction.  The mol wt  of the two  fragments are  67,000  and 40,000 
daltons, respectively, beth of which are larger than the tool wt of C3d (25,000 
daltons) as  isolated from aged or pathological sera  (37). These observations 
indicate that an additional serum enzyme is required for the production of C3c and 
C3d. Trypsin can mimick the serum enzyme, but only subsequent to C3bINA 
and fllH action. The evidence at hand indicates that C3bINA and fllH generate 
only two a'-fragments without production of an intermediate cleavage product 
(85,000 daltons) as described by Gitlin et al.  (36). 
Some uncertainty has existed regarding the mode of regulation of the C4b 
fragment. Cooper (4) purified an enzyme from serum which cleaved and inacti- 
vated C4b and which he called C4b inactivator.  Shiraishi and Stroud (5) re- 
ported that the C4b cleaving enzyme was identical with C3bINA, but that it 
required  a  high molecular weight serum cofactor to  act on cell-bound C4b. 
Schultz and Arnold (39) and later Whaley and Ruddy (8) reported that highly 
purified C3bINA  did not inactivate the  immune adherence function of cell- 
bound C4b, which was originally described by Cooper (40). 
In analogy to C3b regulation, the present study shows that C4b in solution 
was cleaved by C3bINA and ~IH. Neither of the two proteins alone had any 
effect on C4b (Fig. 8). Cleavage of C4b produced two fragments of 150,000 and 
49,000 daltons, respectively, which dissociated in the absence of reducing agents 
(Fig. 9). These findings are in good agreement with mol wt estimates made by 
gel filtration of C4b cleaved by serum enzymes (5) and with the mol wt of intact 
C4b (197,000) as previously described (17). SDS polyacrylamide gel electropho- 
retic analysis of the reduced fragments (Fig. 8) indicated that the C4d portion 
(49,000 daltens) came from the a'-chain of the C4b molecule. No cleavage of 
either the fl or ~ chains was detected. The a'-chain was cleaved during the 2-h 268  HUMAN  c3b  INACTIVATOR 
incubation into the 49,000-dalton C4d fragment, a 29,000-dalton fragment, and a 
fragment in the 10-20,000 mol wt range. Since at least three fragments of the a'- 
chain of C4b were generated, at least two proteolytic cleavages occurred. It seems 
unlikely that two cleavages would be produced by a proteolytic enzyme with the 
extremely restricted specificity C3bINA demonstrated with C3b. It is possible 
therefore  that  an  unidentified  second  enzyme  was  present  in  the  reaction 
mixtures. It remains to be determined which cleavage is effected by C3bINA and 
it  is  conceivable  that,  in  analogy  with  C3b,  the  second  enzyme  causes  the 
cleavage which  generates  the  C4c and  C4d fragments.  Studies  are  currently 
underway to resolve this  question and to identify the  enzyme responsible for 
each cleavage. 
Summary 
The  complement  regulatory  enzyme,  C3b  inactivator  (C3bINA),  has  been 
purified  from  human  serum  by affinity chromatography  on an  anti-C3bINA 
Sepharose  column.  Subsequent  chromatography  on  DEAE-cellulose  and  re- 
moval of IgG with anti-IgG Sepharose resulted in a  product which was found 
to  be  homogeneous  by polyacrylamide  gel  electrophoresis  at  pH  8.9  and  by 
sodium  dodecyl  sulfate  polyacrylamide  gel  electrophoresis.  The  molecule 
is composed of two disulfide bonded polypeptide chains with mol wt of 50,000 and 
38,000 daltons.  Human  C3bINA was found to be a  glycoprotein containing  at 
least 10.7% carbohydrate and to have a  normal serum concentration of 34 _+ 7 
/~g/ml (mean _+ 1 SD). Highly purified C3bINA cleaved neither free C3b nor free 
C4b if trace amounts of contaminating  ~IH were removed from these proteins 
with anti-~lH Sepharose. However, in the presence of highly purified ~IH and 
C3bINA, both C3b and C4b were cleaved. Incubation of native C3 or C4 with 
C3bINA and  ~IH had no effect on their structure.  The action of C3bINA and 
B1H on C3b produced two fragments  of the  d-chain  which did not dissociate 
without reduction of the molecule. These fragments have mol wt of 67,000 and 
40,000 daltons. The action of C3bINA and ~IH on C4b resulted in cleavage of the 
a'-chain  giving rise to the 150,000-dalton C4c and the 49,000-dalton C4d frag- 
ments, which dissociated without reduction. To produce from C3b the immuno- 
chemically defined C3c and C3d fragments,  the action of an additional  serum 
enzyme appears to be required, the effect of which can be mimicked by trypsin. 
Received for publication I  April 1977. 
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